Review
Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part II: Photodynamic Therapy, Vismodegib, Cetuximab, Intralesional Methotrexate, and Radiotherapy
Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte II: terapia fotodinámica, vismodegib, cetuximab, metotrexato intralesional y radioterapia
Leído
7757
Vecesse ha leído el artículo
2447
Total PDF
5310
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 25 | 4 | 29 |
| 2025 5 | 193 | 26 | 219 |
| 2025 4 | 173 | 19 | 192 |
| 2025 3 | 140 | 28 | 168 |
| 2025 2 | 189 | 38 | 227 |
| 2025 1 | 119 | 23 | 142 |
| 2024 12 | 78 | 41 | 119 |
| 2024 11 | 98 | 55 | 153 |
| 2024 10 | 98 | 45 | 143 |
| 2024 9 | 88 | 45 | 133 |
| 2024 8 | 140 | 60 | 200 |
| 2024 7 | 85 | 47 | 132 |
| 2024 6 | 102 | 39 | 141 |
| 2024 5 | 85 | 40 | 125 |
| 2024 4 | 95 | 36 | 131 |
| 2024 3 | 88 | 43 | 131 |
| 2024 2 | 82 | 34 | 116 |
| 2024 1 | 56 | 35 | 91 |
| 2023 12 | 56 | 15 | 71 |
| 2023 11 | 65 | 30 | 95 |
| 2023 10 | 73 | 30 | 103 |
| 2023 9 | 92 | 26 | 118 |
| 2023 8 | 49 | 18 | 67 |
| 2023 7 | 59 | 29 | 88 |
| 2023 6 | 53 | 23 | 76 |
| 2023 5 | 52 | 27 | 79 |
| 2023 4 | 51 | 19 | 70 |
| 2023 3 | 61 | 20 | 81 |
| 2023 2 | 56 | 29 | 85 |
| 2022 1 | 54 | 21 | 75 |
| 2022 12 | 73 | 47 | 120 |
| 2022 11 | 55 | 38 | 93 |
| 2022 10 | 50 | 27 | 77 |
| 2022 9 | 54 | 39 | 93 |
| 2022 8 | 78 | 43 | 121 |
| 2022 7 | 101 | 35 | 136 |
| 2022 6 | 34 | 31 | 65 |
| 2022 5 | 74 | 39 | 113 |
| 2022 4 | 43 | 24 | 67 |
| 2022 3 | 56 | 46 | 102 |
| 2022 2 | 67 | 31 | 98 |
| 2021 1 | 68 | 21 | 89 |
| 2021 12 | 46 | 42 | 88 |
| 2021 11 | 59 | 52 | 111 |
| 2021 10 | 69 | 65 | 134 |
| 2021 9 | 56 | 56 | 112 |
| 2021 8 | 52 | 33 | 85 |
| 2021 7 | 37 | 30 | 67 |
| 2021 6 | 56 | 34 | 90 |
| 2021 5 | 35 | 35 | 70 |
| 2021 4 | 93 | 59 | 152 |
| 2021 3 | 80 | 34 | 114 |
| 2021 2 | 66 | 30 | 96 |
| 2020 1 | 35 | 27 | 62 |
| 2020 12 | 36 | 16 | 52 |
| 2020 11 | 24 | 23 | 47 |
| 2020 10 | 39 | 16 | 55 |
| 2020 9 | 34 | 19 | 53 |
| 2020 8 | 40 | 23 | 63 |
| 2020 7 | 29 | 23 | 52 |
| 2020 6 | 49 | 31 | 80 |
| 2020 5 | 40 | 16 | 56 |
| 2020 4 | 33 | 15 | 48 |
| 2020 3 | 46 | 14 | 60 |
| 2020 2 | 7 | 0 | 7 |
| 2019 12 | 4 | 0 | 4 |
| 2019 9 | 4 | 0 | 4 |
| 2019 6 | 2 | 0 | 2 |
| 2019 5 | 2 | 2 | 4 |
| 2019 4 | 2 | 4 | 6 |
| 2019 3 | 7 | 0 | 7 |
| 2019 1 | 8 | 0 | 8 |
| 2018 12 | 4 | 0 | 4 |
| 2018 11 | 3 | 0 | 3 |
| 2018 10 | 2 | 0 | 2 |
| 2018 9 | 4 | 0 | 4 |
| 2018 2 | 33 | 12 | 45 |
| 2018 1 | 56 | 20 | 76 |
| 2017 12 | 64 | 18 | 82 |
| 2017 11 | 46 | 20 | 66 |
| 2017 10 | 59 | 25 | 84 |
| 2017 9 | 30 | 13 | 43 |
| 2017 8 | 40 | 13 | 53 |
| 2017 7 | 42 | 15 | 57 |
| 2017 6 | 42 | 24 | 66 |
| 2017 5 | 44 | 18 | 62 |
| 2017 4 | 35 | 14 | 49 |
| 2017 3 | 35 | 29 | 64 |
| 2017 2 | 79 | 21 | 100 |
| 2016 1 | 39 | 18 | 57 |
| 2016 12 | 68 | 40 | 108 |
| 2016 11 | 79 | 62 | 141 |
| 2016 10 | 8 | 20 | 28 |
Mostrar todo
